The changes in the signalling and functional effects of novel intracellular immune checkpoint receptors LAG-3, TIGIT and TIM-3, following blockade by ICIs in HNSCC are shown in Figure 3B. The gene discussed is LAG3; the disease is head and neck squamous cell carcinoma.